US SB2901 | 2019-2020 | 116th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on November 19 2019 - 25% progression, died in committee
Action: 2019-11-19 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S6673)
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Establishes the Task Force on Innovative Diabetes Technologies and Services to address the accessibility of innovative diabetes technologies and services to Medicare beneficiaries. The bill defines innovative diabetes technologies and services as medical technologies and services for diabetes treatment that are not covered under Medicare. Among other activities, the task force must (1) recommend ways to improve access to innovative diabetes technologies and services through new or alternative payment models and existing policies, and (2) propose changes to foster collaboration between the Food and Drug Administration and the Centers for Medicare & Medicaid Services to streamline approval and coverage.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019

Sponsors


History

DateChamberAction
2019-11-19SenateRead twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S6673)

Subjects


US Congress State Sources


Bill Comments

feedback